Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Martelli A.,,Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: From bench to bedside,2007,Current Medicinal Chemistry,95,10.2174/092986707781368423,Italy;Italy,Review,Bologna;Bologna,0,Journal,2-s2.0-34548642127
Follo M.,,The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation,2007,Cancer Research,75,10.1158/0008-5472.CAN-06-4409,Italy,Article,Bologna,1,Journal,2-s2.0-34249308840
Deville L.,,"Diagnostics, prognostic and therapeutic exploitation of telomeres and telomerase in leukemias",2006,Current Pharmaceutical Biotechnology,13,10.2174/138920106777549768,France,Review,Paris,0,Journal,2-s2.0-33745108451
Sarbassov D.,,Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB,2006,Molecular Cell,1950,10.1016/j.molcel.2006.03.029,United States;United States,Article,Cambridge;Cambridge,1,Journal,2-s2.0-33646023695
Bae-Jump V.,,"Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest",2006,Gynecologic Oncology,26,10.1016/j.ygyno.2005.08.053,United States,Article,Chapel Hill,0,Journal,2-s2.0-32644476664
Mayerhofer M.,,Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: Dissection of growth-inhibitory and VEGF-suppressive effects of rapamycin in leukemic cells,2005,FASEB Journal,60,10.1096/fj.04-1973fje,Austria,Article,Vienna,0,Journal,2-s2.0-20444445152
Lei W.,,"Positive and negative regulation of c-Myb by cyclin D1, cyclin-dependent kinases, and p27 Kip1",2005,Blood,26,10.1182/blood-2004-08-3342,United States,Article,Albuquerque,0,Journal,2-s2.0-18544372629
Kubuki Y.,,Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia,2005,Leukemia and Lymphoma,45,10.1080/10428190400018349,Japan,Article,Miyazaki,0,Journal,2-s2.0-20844444747
Lee S.H.,,IFN-γ/IRF-1-induced p27<sup>kip1</sup> down-regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer,2005,FEBS Letters,35,10.1016/j.febslet.2005.01.005,South Korea,Article,Jongno-gu,1,Journal,2-s2.0-13844302005
Rowinsky E.,,Targeting the molecular target of rapamycin (mTOR),2004,Current Opinion in Oncology,144,10.1097/01.cco.0000143964.74936.d1,United States,Review,San Antonio,0,Journal,2-s2.0-8344281974
Hay N.,,Upstream and downstream of mTOR,2004,Genes and Development,3063,10.1101/gad.1212704,United States,Review,Chicago,1,Journal,2-s2.0-4043171462
Nishi H.,,Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT),2004,Molecular and Cellular Biology,148,10.1128/MCB.24.13.6076-6083.2004,Japan,Article,Tokyo,1,Journal,2-s2.0-2942709631
Panwalkar A.,,Mammalian Target of Rapamycin Inhibition As Therapy for Hematologic Malignancies,2004,Cancer,192,10.1002/cncr.20026,United States,Review,Houston,1,Journal,2-s2.0-0842304369
Bruemmer D.,,Rapamycin inhibits E2F-dependent expression of minichromosome maintenance proteins in vascular smooth muscle cells,2003,Biochemical and Biophysical Research Communications,19,10.1016/S0006-291X(03)00343-7,Germany;United States,Article,Berlin;Los Angeles,0,Journal,2-s2.0-0037470728
West K.,,Activation of the PI3K/Akt pathway and chemotherapeutic resistance,2002,Drug Resistance Updates,488,10.1016/S1368-7646(02)00120-6,United States,Review,Bethesda,0,Journal,2-s2.0-0036968347
Hudson C.C.,,Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin,2002,Molecular and Cellular Biology,964,10.1128/MCB.22.20.7004-7014.2002,United States,Article,San Diego CA,1,Journal,2-s2.0-0036789574
Cong Y.,,Human telomerase and its regulation,2002,Microbiology and Molecular Biology Reviews,589,10.1128/MMBR.66.3.407-425.2002,United States,Article,Dallas,1,Journal,2-s2.0-0036712072
Gökbuget N.,,Recent approaches in acute lymphoblastic leukemia in adults,2002,Reviews in Clinical and Experimental Hematology,60,10.1046/j.1468-0734.2002.00068.x,Germany,Review,Frankfurt am Main,0,Journal,2-s2.0-0036341295
Dennis P.,,Mammalian TOR: A homeostatic ATP sensor,2001,Science,736,10.1126/science.1063518,,Article,,0,Journal,2-s2.0-0035798097
Hidalgo M.,,The rapamycin-sensitive signal transduction pathway as a target for cancer therapy,2000,Oncogene,539,10.1038/sj.onc.1204091,United States,Review,San Antonio,1,Journal,2-s2.0-0034722888
Schmelzle T.,,"TOR, a central controller of cell growth",2000,Cell,1546,10.1016/S0092-8674(00)00117-3,Switzerland,Review,Basel,1,Journal,2-s2.0-0034644525
Sekulić A.,,A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells,2000,Cancer Research,604,,United States,Article,Rochester,0,Journal,2-s2.0-0034234924
Stewart S.,,Telomerase and human tumorigenesis,2000,Seminars in Cancer Biology,123,10.1006/scbi.2000.0339,United States,Article,Cambridge,0,Journal,2-s2.0-0034472472
Kang S.,,Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit,1999,Journal of Biological Chemistry,416,10.1074/jbc.274.19.13085,South Korea,Article,Seoul,1,Journal,2-s2.0-0033532056
Kyo S.,,Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues,1999,International Journal of Cancer,122,10.1002/(sici)1097-0215(19990105)80:1<60::aid-ijc12>3.0.co;2-e,Japan,Article,Kanazawa,1,Journal,2-s2.0-0033524343
Bodnar A.G.,,Extension of life-span by introduction of telomerase into normal human cells,1998,Science,3823,10.1126/science.279.5349.349,United States,Article,Menlo Park,0,Journal,2-s2.0-0010045614
Nakamura T.,,Telomerase catalytic subunit homologs from fission yeast and human,1997,Science,1966,10.1126/science.277.5328.955,,Article,,0,Journal,2-s2.0-0030819894
Jefferies H.B.J.,,Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70(s6k),1997,EMBO Journal,778,10.1093/emboj/16.12.3693,Switzerland,Article,Basel,0,Journal,2-s2.0-0030915898
Zhu X.,,Cell cycle-dependent modulation of telomerase activity in tumor cells,1996,Proceedings of the National Academy of Sciences of the United States of America,236,10.1073/pnas.93.12.6091,United States,Article,Nutley,1,Journal,2-s2.0-0029941308
Brown E.,,Control of p70 S6 kinase by kinase activity of FRAP in vivo,1995,Nature,599,10.1038/377441a0,United States,Letter,Cambridge,0,Journal,2-s2.0-0029103330
Weinberg R.,,The retinoblastoma protein and cell cycle control,1995,Cell,4104,10.1016/0092-8674(95)90385-2,United States,Review,Cambridge,1,Journal,2-s2.0-0029033861
Feng J.,,The RNA component of human telomerase,1995,Science,1990,10.1126/science.7544491,United States,Article,Menlo Park,0,Journal,2-s2.0-0029096515
Toyoshima H.,,"p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21",1994,Cell,1865,10.1016/0092-8674(94)90573-8,United States,Article,San Diego,0,Journal,2-s2.0-0028363519
Polyak K.,,"Cloning of p27<sup>Kip1</sup>, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals",1994,Cell,1973,10.1016/0092-8674(94)90572-X,United States,Article,Chevy Chase,0,Journal,2-s2.0-0028176483
Baldin V.,,Cyclin D1 is a nuclear protein required for cell cycle progression in G<inf>1</inf>,1993,Genes and Development,1322,10.1101/gad.7.5.812,Germany,Article,Heidelberg,1,Journal,2-s2.0-0027154638
